2b -3a antagonists have revolutinised ACS management .
But the irony is Reo pro is approved for use only inside cath lab or on the way to cath lab ! when PCI is done .
If PCI with stenting is planned, then subsequently cancelled due to minimal coronary lesion or spontaneous reperfusion what will be the effect of Abxicimab on outcome ?
Message 1
Abxicimab (Reopro,Faximab)
Useful only if PCI and stenting is done.
Dont use it for regular managment of UA/NSTEMI
Leave a Reply